U.S. markets open in 8 hours 8 minutes
  • S&P Futures

    4,210.75
    -12.25 (-0.29%)
     
  • Dow Futures

    33,918.00
    -99.00 (-0.29%)
     
  • Nasdaq Futures

    13,921.25
    -60.00 (-0.43%)
     
  • Russell 2000 Futures

    2,302.10
    -8.00 (-0.35%)
     
  • Crude Oil

    71.96
    -0.19 (-0.26%)
     
  • Gold

    1,820.70
    -40.70 (-2.19%)
     
  • Silver

    27.20
    -0.61 (-2.20%)
     
  • EUR/USD

    1.2005
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.5690
    0.0000 (0.00%)
     
  • Vix

    18.15
    +1.13 (+6.64%)
     
  • GBP/USD

    1.3995
    +0.0008 (+0.06%)
     
  • USD/JPY

    110.6830
    +0.0700 (+0.06%)
     
  • BTC-USD

    38,780.46
    -1,424.36 (-3.54%)
     
  • CMC Crypto 200

    964.57
    -27.90 (-2.81%)
     
  • FTSE 100

    7,184.95
    +12.47 (+0.17%)
     
  • Nikkei 225

    29,001.14
    -289.87 (-0.99%)
     

Top Ranked Momentum Stocks to Buy for May 15th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 15th:                  

Halozyme Therapeutics, Inc. (HALO): This biopharma technology platform company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.

Halozyme Therapeutics, Inc. Price and Consensus

Halozyme Therapeutics, Inc. Price and Consensus
Halozyme Therapeutics, Inc. Price and Consensus

Halozyme Therapeutics, Inc. price-consensus-chart | Halozyme Therapeutics, Inc. Quote

Halozyme Therapeutics’ shares gained 28.6% over the last one month compared with the S&P 500 growth 5%. The company possesses a Momentum Score of A.

Halozyme Therapeutics, Inc. Price

Halozyme Therapeutics, Inc. Price
Halozyme Therapeutics, Inc. Price

Halozyme Therapeutics, Inc. price | Halozyme Therapeutics, Inc. Quote

II-VI Incorporated (IIVI): This company that develops, manufactures, and markets engineered materials, and optoelectronic components and devices has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.3% over the last 60 days.

IIVI Incorporated Price and Consensus

IIVI Incorporated Price and Consensus
IIVI Incorporated Price and Consensus

IIVI Incorporated price-consensus-chart | IIVI Incorporated Quote

II-VI’s shares gained 41.4% over the last one month. The company possesses a Momentum Score of A.

IIVI Incorporated Price

IIVI Incorporated Price
IIVI Incorporated Price

IIVI Incorporated price | IIVI Incorporated Quote

Kopin Corporation (KOPN): This company that invents, develops, manufactures, and sells components, subassemblies, head-worn, and hand-held systems has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.

Kopin Corporation Price and Consensus

Kopin Corporation Price and Consensus
Kopin Corporation Price and Consensus

Kopin Corporation price-consensus-chart | Kopin Corporation Quote

Kopin’s shares gained 94.2% over the last one month. The company possesses a Momentum Score of A.

Kopin Corporation Price

Kopin Corporation Price
Kopin Corporation Price

Kopin Corporation price | Kopin Corporation Quote

MEI Pharma, Inc. (MEIP): This late-stage pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

MEI Pharma, Inc. Price and Consensus

MEI Pharma, Inc. Price and Consensus
MEI Pharma, Inc. Price and Consensus

MEI Pharma, Inc. price-consensus-chart | MEI Pharma, Inc. Quote

MEI Pharma’s shares gained 18.6% over the last one month. The company possesses a Momentum Score of A.

MEI Pharma, Inc. Price

MEI Pharma, Inc. Price
MEI Pharma, Inc. Price

MEI Pharma, Inc. price | MEI Pharma, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MEI Pharma, Inc. (MEIP) : Free Stock Analysis Report
 
Kopin Corporation (KOPN) : Free Stock Analysis Report
 
IIVI Incorporated (IIVI) : Free Stock Analysis Report
 
Halozyme Therapeutics, Inc. (HALO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research